logo

For the Inventor, By the Inventor

Westmount, Canada

Angiochem Inc.


USPTO Granted Patents = 17

% Expired Patents = 47.1



Forward Citations = 72

Loading Chart...
Loading Chart...

19 inventors (with patents filed for the assignee):

goldMedal Michel Demeule (15 out of 21 patents)

silverMedal Christian Che (9 out of 9 patents)

bronzeMedal Anthony Regina (7 out of 7 patents)

4.  Jean-Paul Castaigne (6 out of 7 patents)

5.  Richard Béliveau (5 out of 10 patents)

6.  Richard Beliveau (5 out of 10 patents)

7.  Betty Lawrence (4 out of 4 patents)

8.  Catherine Gagnon (4 out of 4 patents)

9.  Gaoqiang Yang (2 out of 7 patents)

10.  Carine Thiot (2 out of 2 patents)

11.  Reinhard Gabathuler (2 out of 5 patents)

12.  Alain Larocque (1 out of 4 patents)

13.  Priya Kumthekar (1 out of 1 patent)

14.  Sasmita Tripathy (1 out of 9 patents)

15.  Jonathan Michaud-Levesque (1 out of 3 patents)


17 patents:

1. 10980892 - Methods for the treatment of leptomeningeal carcinomatosis (2021-04-20),
2. 9914754 - Conjugates of neurotensin or neurotensin analogs and uses thereof (2018-03-13),
3. 9713646 - Potentiation of anticancer agents (2017-07-25),
4. 9687561 - Peptide-dendrimer conjugates and uses thereof (2017-06-27),
5. 9365634 - Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues (2016-06-14),
6. 9221867 - Method for transporting a compound across the blood-brain barrier (2015-12-29),
7. 9173891 - Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog (2015-11-03),
8. 9161988 - Multimeric peptide conjugates and uses thereof (2015-10-20),
9. 8969310 - Potentiation of anticancer agents (2015-03-03),
10. 8921314 - Conjugates of GLP-1 agonists and uses thereof (2014-12-30),
11. 8853353 - Membrane type-1 matrix metalloprotein inhibitors and uses thereof (2014-10-07),
12. 8828949 - Aprotinin polypeptides for transporting a compound across the blood-brain barrier (2014-09-09),
13. 8828925 - Etoposide and doxorubicin conjugates for drug delivery (2014-09-09),
14. 8710013 - Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use (2014-04-29),
15. 8487072 - Compounds for stimulating P-glycoprotein function and uses thereof (2013-07-16),
Company Overview
Angiochem Inc. is a biotechnology company based in Westmount, Canada, specializing in the development of innovative drug delivery systems. The company focuses on enhancing the transport of therapeutic agents across biological barriers, particularly the blood-brain barrier, to improve treatment outcomes for central nervous system disorders. Angiochem's proprietary technology platform aims to facilitate the effective delivery of a range of biologics and small molecules, positioning the company at the forefront of advancements in targeted drug delivery solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

17 Patents

#1 in Westmount

#884 in Canada

#35,948 in the World

Westmount, CA
Westmount, Canada

Angiochem Inc.

Forward Citations = 72

19 inventors:

goldMedal Michel Demeule (15 out of 21 patents)

silverMedal Christian Che (9 out of 9 patents)

bronzeMedal Anthony Regina (7 out of 7 patents)

4.  Jean-Paul Castaigne (6 out of 7 patents)

5.  Richard Béliveau (5 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Angiochem Inc.. Retrieved from https://idiyas.com/company/angiochem

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…